ÂÜÀòÂÒÂ×

Ursula Busse is an experienced regulatory affairs professional currently serving as the Head of Regulatory Affairs at Tigen, responsible for overseeing regulatory strategies and operations for innovative cell-based immuno-therapies. Prior to Tigen, Ursula held key leadership roles at Boehringer Ingelheim, where the focus was on building a regulatory intelligence and policy organization, and at Novartis, contributing to GxP intelligence and external engagement strategies. Ursula's career includes significant positions in regulatory affairs and quality assurance at Medicago and Novartis, complemented by an extensive academic background with multiple advanced degrees from Université Laval and the University of Tübingen in molecular biology and business administration.